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Background: Traditional healers use Boophane disticha to treat several neurodegenerative diseases. Furthers studies 
need to be carried out to justify its use in traditional medicine. 
Objective: The objective of this study was to evaluate the acetylcholinesterase (AChE) inhibitory activity as well as 
the antioxidant activity of the bulbs and roots of B. disticha. Cytotoxicity studies were carried out to evaluate its safety.  
Methodology: Ethyl acetate and methanol extracts of the plant were screened for AChE inhibitory activity using the 
Ellman’s colorimetric method. ABTS and DPPH radical scavenging assays were carried out to determine antioxidant 
activity. Cytotoxicity assessment was determined on human neuroblastoma (SH-SY5Y) cells using the MTT and 
neutral red uptake assays. 
Results: All plant extracts tested exhibited AChE inhibitory activity, with the ethyl acetate extract of the bulb and 
methanol extract of the root showing the highest activity. Antioxidant activity was only observed with the methanol 
extract of the roots with IC50 values of 0.086 mg/ml and 0.13 mg/ml in both the ABTS and DPPH assays, respectively. 
The extract also exhibited low IC50 values in the cytotoxicity assays.  
Discussion: These findings partially support the traditional use of B. disticha in the treatment of neurological 
disorders. Its use may however be limited by its toxicity. 
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1. Introduction 
Alzheimer’s disease (AD) is the most common 
neurodegenerative disease and is characterized by 
memory impairment, cognitive dysfunction, behavioral 
disturbances and deficits in daily living (Konrath et al, 
2012). Approaches to enhance cholinergic function in 
AD have included stimulation of cholinergic receptors 
or prolonging the availability of acetylcholine (ACh) 
released into the neuronal synaptic cleft by inhibiting 
ACh hydrolysis through the use of acetylcholinesterase 
(AChE) inhibitors (Howes and Houghton, 2003). Tacrine 
was the first widely used AChE inhibitor (Summers, 
2006). Second generation AChE inhibitors with longer 
half-lives than tacrine, such as donepezil, galanthamine 
and rivastigmine, have since been developed and are 
currently in use (Shah et al, 2008). In addition, several 
lines of evidence indicate that reactive oxygen species 
are associated with the pathogenesis of AD, as some 
cellular characteristics of this disease are either causes 
or effects of oxidative stress (Zhu et al, 2004; Sultana et 
al, 2006; Konrath et al, 2012). Generally, the 
physiological role of antioxidant compounds is to 
attenuate the oxidation chain reactions by removing 
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free-radical intermediates (Liu and Nair, 2010). Since a 
large amount of evidence demonstrates that oxidative 
stress is intimately involved in age-related 
neurodegenerative diseases, there have been a number 
of studies which have examined the positive effects of 
antioxidants in reducing or blocking neuronal death 
occurring in the pathophysiology of these disorders 
(Ramassamy, 2006). Consequently, the use of 
antioxidants has been explored in an attempt to slow 
AD progression and neuronal degeneration (Howes and 
Houghton, 2003).  
Toxicity testing is an essential requirement for the 
development of modern pharmaceutical compounds. 
Medicinal plants are assumed to have low toxicity due 
to their long-term consumption by humans and animals 
(Luseba et al, 2007; Verschaeve and van Staden, 2008; 
Aremu et al, 2011). However, several studies have 
shown that many plants used as food or medicine, have 
potential toxic effects (Du Plooy et al, 2001; Barlow and 
Schlatter, 2010). Almost all known AChE inhibitors have 
several drawbacks, such as hepatotoxicity, short 
duration of biological action, low bioavailability, 
adverse cholinergic side effects in the periphery and 
narrow therapeutic windows (Lee et al, 2011). Some 
common synthetic antioxidants including butylated 
hydroxyanisole (BHA) and butylated hydroxytoluene 
(BHT) have been reported to be toxic (Aremu et al, 
2011). Therefore, the search for new AChE inhibitors 
and antioxidants, particularly from natural products, 
with low toxicity and higher efficacy continues. 
Many plants are reputed to have ‘anti-ageing’ or 
‘memory-enhancing’ effects and are used traditionally 
to treat several neurodegenerative diseases (Howes and 
Houghton, 2003). One such plant, Boophane disticha 
(L.f.) Herb. belongs to the family Amaryllidaceae. It is an 
attractive, deciduous bulbous plant with a thick 
covering of dry scales above the ground and is widely 
distributed in Africa, ranging from Sudan in the north to 
the Western Cape Province in the south (Wrinkle, 
1984). Decoctions of bulb scales are given to sedate 
violent, psychotic patients while bulb infusions are 
reported to be used to treat mental illness (van Wyk 
and Gericke, 2000; Sobiecki, 2002). Bulb decoctions are 
also used in the treatment of headaches, abdominal 
pain, weakness, sharp chest pains and persistent 
bladder pains, as well as treatment of varicose ulcers, 
relief of urticaria, and cancer (Botha et al, 2005). This 
study was aimed at evaluating the AChE inhibitory and 
antioxidant activity of the bulbs and roots of B. disticha 
to partially justify its traditional use in treatment of 
neurodegenerative diseases. The safety of using this 
plant in traditional medicine was also investigated by 
assessing its toxicity using the MTT and neutral red 
assays. 
2. Methods 
2.1 Reagents and Chemicals 
Acetylthiocholine iodide (ATCI), acetylcholinesterase 
(AChE) type VI-S from an electric eel, 5,5´-dithiobis [2-
nitrobenzoic acid] (DTNB), galanthamine, 1,1-diphenyl-
2-picrylhydrazyl (DPPH), 2,2´-azinobis-3-
ethylbenzothiazoline-6-sulfonic acid (ABTS), trolox, 3-
[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium 
bromide (MTT), and neutral red dye, were all purchased 
from Sigma Aldrich (South Africa). Ham’s F-12 medium, 
fetal calf serum (FCS) and other cell culture reagents 
were obtained from Gibco Invitrogen Corporation. All 
organic solvents (analytical grade) were purchased 
from Merck (South Africa). 
2.2 Plant collection and extract preparation 
The bulbs and roots of Boophane disticha (L.f.) Herb. 
(Amaryllidaceae) were a gift from the South African 
National Biodiversity Institute (Tshwane). The root and 
bulb were separated, cut into small pieces and air-dried 
at room temperature. The dried material was ground to 
a fine powder using an Ika Analytical Mill (Staufen, 
Germany), and stored at ambient temperature in the 
dark till use. Six grams of the powdered plant material 
was extracted with 60 ml of either methanol or ethyl 
acetate for 24 h while shaking. The extracts were 
filtered and evaporated to dryness using a rotary 
evaporator. All extracts were stored at -20 °C prior to 
analysis. The residues were re-dissolved in either MeOH 
or ethyl acetate to the desired test concentrations. 
2.3 Micro-plate assay for inhibition of 
acetylcholinesterase 
Inhibition of acetylcholinesterase activity was 
determined using Ellman’s colorimetric method as 
modified by Eldeen et al (2005). Into a 96-well plate 
was placed: 25 µl of 15 mM ATCI in water, 125 µl of 3 
mM DTNB in Buffer A (50 mM Tris-HCl, pH 8, containing 
0.1 M NaCl and 0.02 M MgCl2.6H2O), 50 µl of Buffer B 
(50 mM, pH 8, containing 0.1% bovine serum albumin) 
and 25 µl of plant extract (0.007, 0.016, 0.031, 0.063 or 
0.125 mg/ml). Absorbance was determined 
spectrophotometrically (Labsystems Multiscan EX type 
355 plate reader) at 405 nm at 45 sec intervals, three 
times consecutively. Thereafter, AChE (0.2 U/ml) was 
added to the wells and the absorbance measured five 
times consecutively every 45 sec. Galanthamine served 
as the positive control. Any increase in absorbance due 
to the spontaneous hydrolysis of the substrate was 
corrected by subtracting the absorbance before 
addition of the enzyme from the absorbance after 
addition of the enzyme. The percentage inhibition for 
each test solution was then calculated using the 
equation: 
Inhibition (%) = 1 – (Asample/Acontrol) × 100   
Where Asample is the absorbance of the sample extracts 
and Acontrol is the absorbance of the blank [methanol in 
50 mM Tris-HCl, (pH 8)]. Extract concentration 
providing 50% inhibition (IC50) was obtained by 
plotting the percentage inhibition against extract 
concentration. 
2.4 Antioxidant activity 
DPPH radical scavenging activity 
The effect of the extracts on DPPH radical was 
estimated using the method of Liyana-Pathirana and 
Shahidi (2005), with minor modifications. A solution of 
0.135 mM DPPH in methanol was prepared and 185 µl 
of this solution was added to 15 µl of varying 
concentrations of the extract (0.007, 0.016, 0.031, 0.063 
or 0.125 mg/ml), in a 96-well plate. The reaction 
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mixture was vortexed and left in the dark for 30 min 
(room temperature). The absorbance of the mixture 
was determined at 570 nm using a microplate reader. 
Trolox was used as the reference antioxidant 
compound. The ability to scavenge the DPPH radical 
was calculated using the equation: 
DPPH radical scavenging activity (%) = [(Acontrol – 
Asample)/Acontrol] × 100 
where Acontrol is the absorbance of DPPH radical + 
methanol and Asample is the absorbance of DPPH radical 
+ sample extract/standard. The extract concentration 
providing 50% inhibition (IC50) was obtained by 
plotting inhibition percentage versus extract 
concentration. 
ABTS radical scavenging activity 
The method of Re et al (1999) was adopted for the 
ABTS assay. The stock solution which was allowed to 
stand in the dark for 16 hr at room temperature 
contained equal volumes of 7 mM ABTS salt and 2.4 mM 
potassium persulfate. The resultant ABTS*+ solution was 
diluted with methanol until an absorbance of 0.706 ± 
0.001 at 734 nm was obtained. Varying concentrations 
(0.007, 0.016, 0.031, 0.063 or 0.125 mg/ml) of the 
extract were allowed to react with 2 ml of the ABTS*+ 
solution and the absorbance readings were recorded at 
734 nm. The ABTS*+ scavenging capacity of the extract 
was compared with that of trolox and the percentage 
inhibition calculated as: 
ABTS radical scavenging activity (%) = [(Acontrol – 
Asample)/Acontrol] × 100 
Where Acontrol is the absorbance of ABTS radical + 
methanol and Asample is the absorbance of ABTS radical + 
sample extract/standard. The extract concentration 
providing 50% inhibition (IC50) was obtained by 
plotting inhibition percentage versus extract 
concentration. 
2.5 Cells and cell culture 
The neuroblastoma cell line, SH-SY5Y (ATCC CRL-2266) 
was selected for this study as it has been widely used in 
experimental neurological studies, including analysis of 
neuronal differentiation, metabolism and function 
related to neurodegenerative and neuronadaptive 
processes, neurotoxicity and neuroprotection (Xie et al, 
2010). It was purchased from American Type Culture 
Collection.  
Cells were cultured in Ham’s F-12 supplemented with 
2% heat-inactivated fetal bovine serum, penicillin (100 
U/ml) and streptomycin (100 µg/ml) at 37 °C in a 
humidified incubator at 95% air and 5% CO2.  
For use in the assay, the cells were trypsin-treated for 
10 min, decanted from culture flasks and centrifuged 
(200g, 10 min). The pellet was re-suspended in 1 ml 
fetal calf serum-supplemented Ham’s F-12 medium and 
enumerated by staining with trypan blue. The cells were 
diluted to a concentration of 1 × 105 cells/well in Ham’s 
F-12 medium and 100 µl of the cell suspension plated 
into each of the wells of a 96-well microtiter plate. 80 µl 
of Ham’s F-12 medium was added whereafter plates 
were incubated for 1 hr at 37 °C in a humidified 
incubator at 95% air and 5% CO2 to allow for cellular 
re-attachment. 
2.6 Cytotoxicity studies 
MTT assay 
The MTT assay as described by Mossmann (1983) was 
used to measure cell viability. The principle of the assay 
is based on generation of formazan, a blue product, in 
the mitochondria of active cells which is measured by 
photometric techniques (Hansen et al, 1989). The cells 
were plated into 96-well culture plates, as described 
above, and treated with various concentrations (100, 
50, 25, 12.5, 6.25, 3.125, 1.56 and 0.78 μg/ml) of the 
plant extracts for 72 hr. Thereafter, 20 μl of MTT 
solution (5 mg/ml) was added to the wells and further 
incubated for 3 hr. 50 μl of solution containing 30% 
(w/v) N,N- dimethylformamide and 20% SDS in water 
was then added to breach the cells and dissolve the 
formazan crystals.  
The plates were incubated overnight at 37 °C, after 
which absorbance was measured at 570-630 nm using a 
microtiter plate reader (Labsystems Multiscan EX type 
355). Wells without cells were used as blanks and were 
subtracted as background from each sample. Cell 
viability was expressed as a percentage of the control 
values. Extract concentration providing 50% inhibition 
(IC50) was calculated from the graph of inhibition 
percentage versus extract concentration. 
Neutral red assay 
The neutral red uptake assay as described by 
Borenfreund and Puerner (1984) was also used to 
assess cell viability. This method is based on the 
determination of the accumulation of the neutral red 
dye in the lysosomes of viable, uninjured cells. After 
treatment and incubation of the cells (as described 
above for the MTT assay), 150 µl of neutral red dye (100 
µg/ml) dissolved in serum free medium (pH 6.4), was 
added to the culture medium for 3 hr at 37 °C. Cells 
were washed with Phosphate Buffered Saline (PBS), and 
150 μl of elution medium (EtOH/AcOH/H2O, 
50%/1%/49%) was added followed by gentle shaking 
for 60 min, so that complete dissolution could be 
achieved.  
Absorbance was recorded at 540-630 nm using a 
microtiter plate reader (Labsystems Multiscan EX type 
355). Cell viability was expressed as a percentage of the 
control values. A graph of percentage cell viability 
against extract concentration was plotted, and extract 
concentration providing 50% inhibition (IC50) of cell 
death was calculated from the graph. 
2.6 Statistical analysis 
Tests were carried out where possible at least in 
triplicate and on three different occasions. The results 
are reported as mean ± standard deviation (S.D.). 
Standard curves were generated and calculation of the 
50% inhibitory concentration (IC50) values was done 
using GraphPad Prism Version 4.00 for Windows 
(GraphPad Software Inc.). Cytotoxicity results are 
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expressed as the percentage cell survival compared to 
the untreated control using a dose response curve.  
3. Results and Discussion 
The results of the AChE inhibitory activities of the 
extracts of B. disticha, as well as the positive control, 
galanthamine, are provided in Figure 1. All the plant 
extracts tested contained some level of inhibition 
against AChE. The ethyl acetate extract of the bulb and 
methanol extract of the root showed the highest activity 
with AChE inhibitory values of 66.4% and 76.3%, 
respectively, at the highest concentration tested (0.125 
mg/ml). The IC50 values, of the plant extracts, indicating 
AChE inhibitory activity are presented in Table 1. With 
the exception of the methanol extracts of the bulbs, all 
other extracts tested had low IC50 values. Although the 
IC50 of these plant extracts were higher than that of 
galanthamine (0.00053 mg/ml), they possess good 
AChE inhibitory activity considering they are still 
mixtures containing various compounds. 
 
Figure 1 Percentage inhibition of acetylcholinesterase by the ethyl acetate and methanol extracts of (A) roots and (B) 
bulbs of Boophanedisticha. BRM, B. disticha root methanol extract; BRE, B. disticha root ethyl acetate extract; BBM, B. 
disticha bulb methanol extract; BBE, B. disticha bulbs ethyl acetate extract; Gal, Galanthamine. 
 
 
 
 
 
 
 
Figure 2 Effect of the methanol extract of B. disticha 
roots on the viability of SH-SY5Y cell lines as measured 
by MTT and neutral red uptake assays after 72 hr of 
incubation 
 
 
Table 1 AChE inhibitory activity of extracts of B. 
disticha as represented by their IC50 values. 
Plant part 
analyzed 
Extraction 
solvent 
AChE inhibitionIC50 
(mg/ml) 
Bulb Methanol * 
 Ethyl acetate 0.0073 ± 0.002 
Root Methanol 0.0199 ± 0.009 
 Ethyl acetate 0.0230 ± 0.007 
Galanthamine  5.3 × 10-4 ± 1.0 × 10-5 
* represents extracts with maximum inhibition below 50% at 
the highest concentration tested 
 
Leaf extracts of B. disticha have been shown to contain 
neuroprotective activity through possession of affinity 
for the serotonin transporter in rat brain (Nielsen et al, 
2004). A number of biologically active alkaloids, 
including buphanidrine, buphanamine, crinine, lycorine, 
distichamine and lycorine have been isolated from B. 
disticha. Several of these compounds have been 
reported to show moderate to high affinity for the 
serotonin transporter (Elgorashi et al, 2006). Some of 
these alkaloids, as well as similar alkaloids, isolated 
from other plants in the Amaryllidaceae family have 
been reported to contain AChE inhibitory activity. 
Crinine, epibuphanisine, crinamidine and epivittatine 
have been isolated from Crinum moorei (Elgorashi et al, 
2001a); hamayne from C. macowanii (Elgorashi et al, 
2001b) and 3-O-acetylhamayne and crinamine from C. 
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bulbispermum. Inhibition of AChE (IC50) was shown to 
be 461 ± 14 µM, 547 ± 5 µM, 300 ± 27 µM, 239 ± 9 µM, 
553 ± 3µM, 594 ± 8 µM, and 697 ± 12 µM for each of 
these alkaloids, respectively (Elgorashi et al, 2004). The 
presence of these or related alkaloids may be 
responsible for the good AChE inhibitory activity 
observed with the methanol and ethyl acetate extracts 
of the bulbs and root of B. disticha. 
The ethyl acetate extract of the bulb and root, and 
methanol extract of the bulb did not show any 
antioxidant activity (results not shown). Antioxidant 
activity was however observed, with the methanol 
extract of the root in both the ABTS and DPPH assays 
with IC50 values of 0.086 mg/ml and 0.13 mg/ml 
respectively. The extract scavenged the ABTS and DPPH 
radicals in a dose-dependent manner, though 
antioxidant activity observed was lower than that of 
trolox (positive control) which had IC50 values of 0.013 
mg/ml and 9.6 × 10-6 mg/ml for both the ABTS and 
DPPH assays, respectively. Lycorine and 
haemanthamine have been reported to contain 
antioxidant activity (Oloyede et al, 2010), and the 
presence of these or similar Amaryllidaceae alkaloids 
may be responsible for the observed antioxidant 
activity in the methanol extract of the root of B. disticha. 
This is the first report on the antioxidant activity of 
crude extracts of B. disticha.  
The methanol extract of the root of B. disticha was 
further tested for its toxicity as it showed good AChE 
inhibitory and antioxidant activity. The effect of the 
extract on the viability of SH-SY5Y cell lines using the 
MTT and neutral red assay is presented in Figure 2. 
Results obtained from both cytotoxicity assays were 
comparable and the extract showed IC50 values of 23.3 
µg/ml and 27.8 µg/ml for the MTT and neutral red 
assays respectively. The low IC50 values obtained 
showed that the extract is toxic and this is not 
surprising as the toxic effect of B. disticha is 
documented in literature and this is mainly due to its 
alkaloidal content (Botha et al, 2005). The 
Amarrylidaceae alkaloids lycorine, crinamine and 
augustine have been reported to demonstrate 
significant cytotoxic activity in 12 different cell lines 
(Likhitwitayawuid et al, 1993). Also, crinafolidine and 
crinafoline have been observed to produce significant 
reduction in the viability and in vivo growth of S-180 
ascites tumor cells (Tram et al, 2002). 
4. Conclusion 
The present study showed that the ethyl acetate and 
methanol extracts of the bulbs and roots have good 
AChE inhibition. In addition, the methanol extract of the 
roots contains antioxidant activity which partially 
supports the traditional use of the plant for treating 
neurological disorders. However, its use may be limited 
by its toxicity. 
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